Nitrous oxide

Description

Nitrous Oxide USP is a colorless, non-flammable gas with a slightly sweet odor and taste. Its chemical name is nitrous oxide, and it has a CAS number of 10024-97-2.

Uses and Indications

Nitrous Oxide is indicated for use in medical settings under the supervision of a licensed practitioner experienced in its administration. This drug is utilized for its anesthetic properties, providing analgesia and sedation during various medical procedures.

Limitations of use include the necessity for administration by qualified personnel to ensure safety and efficacy. There are no specific teratogenic or nonteratogenic effects associated with Nitrous Oxide noted in the available data.

Dosage and Administration

Administration of Nitrous Oxide is to be conducted exclusively by or under the supervision of a licensed practitioner who possesses experience in the use and administration of this agent, as its use may pose hazards or contraindications.

The route of administration is via respiratory inhalation. The active ingredient is Nitrous Oxide, provided in a concentration of 990 mL within a 1 L container. It is imperative that practitioners adhere to established safety protocols and guidelines when administering Nitrous Oxide to ensure patient safety and efficacy of treatment.

Contraindications

Administration of Nitrous Oxide is contraindicated in situations where safety precautions have not been fully understood and implemented.

Healthcare professionals should ensure that all safety measures are adhered to prior to handling the gas. Inhalation of the gas should be avoided to prevent respiratory complications. Additionally, contact with eyes, skin, or clothing must be strictly avoided to mitigate the risk of irritation or injury.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses expertise in its administration. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazards and Risks Nitrous Oxide is classified as an oxidizer and may cause or intensify fire. It is stored as a gas under pressure, which presents a risk of explosion if subjected to heat. Users should be aware that exposure to Nitrous Oxide may lead to drowsiness or dizziness, and there is a risk of oxygen displacement, which can result in rapid suffocation. Additionally, contact with the gas may cause frostbite.

General Precautions Prior to handling Nitrous Oxide, it is essential that all safety precautions are thoroughly read and understood. The gas should be stored away from clothing and other combustible materials, and care must be taken to keep valves and fittings free from grease and oil. Users should avoid inhaling the gas and ensure that it does not come into contact with eyes, skin, or clothing.

Nitrous Oxide should only be used and stored outdoors or in well-ventilated areas. In the event of a fire, efforts should be made to stop the leak if it is safe to do so. A backflow preventive device should be utilized in the piping, and only equipment made from compatible materials and rated for cylinder pressure should be employed. Equipment must also be cleaned for oxygen service. Valves should be opened slowly and closed after each use and when empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). It is crucial to read and follow the Safety Data Sheet (SDS) prior to use.

Emergency Instructions In case of feeling unwell, it is advised to contact a poison center or a physician immediately. If skin contact occurs, it is important to seek immediate medical advice. Affected areas should be thawed with lukewarm water, and rubbing the area should be avoided to prevent further injury.

Side Effects

The administration of Nitrous Oxide is associated with several adverse reactions that may vary in seriousness and frequency.

Serious adverse reactions include the potential for drowsiness or dizziness, which may impair the ability to perform tasks requiring alertness. Additionally, Nitrous Oxide is classified as an oxidizer and poses a significant danger as it may cause or intensify fire. There is also a risk of rapid suffocation due to the displacement of oxygen, which can lead to severe respiratory complications. Furthermore, exposure to Nitrous Oxide can result in frostbite, particularly if the gas is released inappropriately or handled without proper precautions.

It is important to note that the administration of Nitrous Oxide may be hazardous or contraindicated in certain patients. Therefore, it should only be used by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be well-informed about the associated hazards, contraindications, and potential side effects to ensure patient safety.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use of Nitrous Oxide is not specifically addressed in the available prescribing information. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for pediatric patients mentioned in the insert. Healthcare professionals should exercise caution and consider the lack of specific data when administering Nitrous Oxide to children.

Geriatric Use

Elderly patients do not have specific geriatric use considerations, dosage adjustments, safety concerns, or special precautions outlined in the provided information. Therefore, healthcare providers may not need to implement any additional measures when prescribing this medication to geriatric patients. However, as with all medications, it is advisable to monitor elderly patients closely for any potential adverse effects or changes in response to treatment.

Pregnancy

The administration of Nitrous Oxide during pregnancy may pose risks to the fetus and is considered hazardous or contraindicated. Healthcare professionals should exercise caution when considering the use of Nitrous Oxide in pregnant patients due to the potential adverse effects on fetal outcomes. It is essential to evaluate the risks versus benefits in this population and to explore alternative options when necessary.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrous Oxide in lactating mothers. Additionally, there is no information available about the potential for excretion of Nitrous Oxide in breast milk or any related considerations for breastfeeding. Therefore, healthcare professionals should exercise clinical judgment when advising lactating mothers on the use of this agent.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the insert for Nitrous Oxide. Healthcare professionals should exercise caution and consider the lack of data when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering Nitrous Oxide to patients with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular instability, or gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or toxicology experts for further guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, the importance of prompt recognition and appropriate management cannot be overstated.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Postmarketing experience has revealed the following adverse reactions reported voluntarily or through surveillance programs: drowsiness, dizziness, and frostbite. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards and is contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who is experienced in its use and familiar with its indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide, including its ability to cause or intensify fire, as it is classified as an oxidizer. They should understand that the gas is stored under pressure and may explode if subjected to heat. Additionally, patients should be informed that Nitrous Oxide may cause drowsiness or dizziness, and it can displace oxygen, leading to rapid suffocation. Frostbite is also a risk if the gas comes into contact with skin.

It is crucial for patients to read and understand all safety precautions before handling Nitrous Oxide. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should avoid breathing in the gas and should take care to prevent contact with eyes, skin, or clothing. The use and storage of Nitrous Oxide should only occur outdoors or in well-ventilated areas.

In the event of a fire, patients should be advised to stop the leak if it is safe to do so. They should use a backflow preventive device in the piping and ensure that only equipment made of compatible materials and rated for cylinder pressure is utilized. Equipment must be cleaned for oxygen service, and patients should open the valve slowly and close it after each use or when empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F).

Patients should be encouraged to read and follow the Safety Data Sheet (SDS) prior to use. In case of an emergency, if Nitrous Oxide is inhaled, patients should be removed to fresh air and kept comfortable for breathing, and they should seek medical attention if they feel unwell. If the gas comes into contact with skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and should seek immediate medical advice or attention.

Storage and Handling

The product is supplied in configurations that ensure safe handling and storage. It is essential to keep the product away from clothing and other combustible materials to prevent fire hazards. Valves and fittings must be maintained free from grease and oil to ensure proper functioning and safety.

For optimal use and storage, the product should only be utilized outdoors or in a well-ventilated area. It is crucial to protect the product from direct sunlight when the ambient temperature exceeds 52°C (125°F) to prevent degradation or potential hazards.

When operating the valve, it should be opened slowly to avoid sudden pressure changes. Additionally, the valve must be securely closed after each use and when the product is empty to maintain safety and integrity.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by FULLERTON WELDING SUPPLY. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)